Posted On: 10/30/2014 12:46:14 PM
Post# of 30066

Re: biotechexpert #9931
Yah, they will uplist to the Nasdaq Capital Market via the 5505(b)(2) option, in my opinion. That is, rather than the 5505(b)(1) option which has a higher required Closing Price.

